ENDO 2026 Topical Areas

November 19, 2025

NEUROENDOCRINOLOGY AND PITUITARY

  • Antidiuretic Hormone Disorders
  • Cushing Disease
  • Disorders Of Growth Hormone 
  • Ectopic Cushing 
  • Genetics And Development (Including Gene Regulation) 
  • GHRH, GH, And IGF Biology and Prolactin Biology and Signaling 
  • GnRH and Gonadotroph Biology and Signaling 
  • Hypopituitarism 
  • Neuroendocrine Tumors 
  • Non-Functioning Pituitary Tumors and Other Sellar/Parasellar Tumors 
  • Other Functioning Pituitary Tumors 
  • Pituitary Development, Biology, and Signaling 
  • Prolactinoma 

REPRODUCTIVE ENDOCRINOLOGY 

  • Female Reproductive Health and Biology 
  • Genetics and Development (including gene regulation) 
  • Hyperandrogenic Disorders (Non-PCOS) 
  • Male Reproductive Health and Biology (including reproductive tract) 
  • Menopause 
  • Ovarian Insufficiency and Sex Determination 
  • Polycystic Ovary Syndrome (PCOS) 
  • Reproductive Axis Development and Sex Determination 
  • Transgender Medicine and Research in Adults and Adolescents 

PEDIATRIC AND ADOLESCENT ENDOCRINOLOGY 

  • Disorders of Sex Development or Intersex 
  • General Pediatric Endocrinology 
  • Genetics and Development (including gene regulation) 
  • Pediatric Adrenal Health and Disease 
  • Pediatric Bone and Mineral Metabolism 
  • Pediatric Diabetes, Metabolic, and Cardiovascular Disorders 
  • Pediatric Endocrine Neoplasia and Neuroendocrine Disorders 
  • Pediatric Growth Disorders 
  • Pediatric Obesity 
  • Pediatric Thyroid 
  • Pubertal Development and Disorders 

RECEPTOR BIOLOGY AND SIGNAL TRANSDUCTION 

  • Endocrine Disrupting Chemicals (environmental and man-made chemicals) 
  • Non-Nuclear Receptor Signaling: GPCRs, Receptor Tyrosine Kinases and Cytokine Receptors 
  • Nuclear Receptor Biology and Actions 

CARDIOVASCULAR ENDOCRINOLOGY 

  • Lipids 
  • Primary Aldosteronism: Genetics, Physiopathology, and Diagnosis 
  • Primary Aldosteronism: Subtyping and Treatment 
  • Renin-Angiotensin-Aldosterone system (not including primary aldosteronism) 
  • Vascular Disease and Pathophysiology  

TUMOR BIOLOGY 

  • Endocrine Neoplasia (including MEN, VHL, and carcinoid; excluding thyroid neoplasia) 
  • Cancer Targets and Therapies 
  • Hormone-Dependent Tumors 
  • Tumor Environment, Progression, and Metastasis 
  • Tumorigenesis, Biomarkers, and Diagnostics 

THYROID BIOLOGY AND DISEASE 

  • Benign Thyroid Disorders (other) 
  • Hyperthyroidism (autoimmune) 
  • Hypothyroidism (autoimmune) 
  • Papillary Thyroid Cancer 
  • Thyroid Autoimmunity (Basic) 
  • Thyroid Cancer (other than PTC) 
  • Thyroid Eye Disease 
  • Thyroid Hormone Action 
  • Thyroid Hormone Regulation  
  • Thyroid Nodules 

ADRENAL (EXCLUDING MINERALOCORTICOIDS) 

  • Adrenal Insufficiency  
  • Adrenal Adenomas and Hyperplasia 
  • Congenital Adrenal Hyperplasia 
  • General Adrenal  
  • Glucocorticoid Actions 
  • Other Adrenal Tumors 
  • Pheochromocytoma: Diagnosis and Treatment 
  • Pheochromocytoma: Genetics and Biomarkers 

DIABETES AND VASCULAR DISEASE 

  • Beta Cell Dynamics and Islet Biology 
  • Clinical management of T1D 
  • Diabetes and Pregnancy 
  • Diabetes Technology 
  • Genetics (including gene regulation) and Epidemiology 
  • Glucose Metabolism and Pre-Diabetes 
  • Hypoglycemia 
  • Immunology and Transplantation 
  • Insulin Signaling and Action 
  • Microvascular or Macrovascular Disease in Diabetes 
  • Non-Vascular Complications of Diabetes in the Nervous and Musculoskeletal Systems 
  • Non-Vascular Complications of Diabetes in the Respiratory and Gastrointestinal Systems 
  • Pharmacologic Management of Type 2 Diabetes Using Oral Anti-Diabetic Agents 
  • Pharmacologic Management of Type 2 Diabetes Using Injectable Therapies 
  • Prevention of Type 2 Diabetes and Non-Pharmacologic Management of Type 2 Diabetes 

ADIPOSE TISSUE, APPETITE, AND OBESITY 

  • Adipocyte Biology 
  • Central Regulation of Appetite and Feeding 
  • Diagnosis of Obesity and Related Complications 
  • Emerging Pharmacotherapies Targeting Obesity and Cardiometabolic Diseases: Mechanisms and Efficacy 
  • Genetics and Development (including gene regulation) 
  • GI Regulatory Peptides (excluding insulin) 
  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 
  • Monogenic and Syndromic Obesity 
  • Non-Pharmacologic Management of Obesity 
  • Therapeutics of Obesity 
  • Weight Regain 

BONE AND MINERAL METABOLISM 

  • Biology and Preclinical Studies in Bone and Mineral Disorders 
  • Genetic and Rare Bone and Mineral Metabolism Disorders 
  • Hypocalcemia and Hypoparathyroidism 
  • Non-PTH Hypercalcemia 
  • Osteoporosis in Special Populations 
  • Other Bone Conditions 
  • Phosphate Disorders 
  • Postmenopausal Osteoporosis 
  • Preclinical Calcium, Parathyroid Hormone, and Vitamin D 
  • Primary Hyperparathyroidism 
  • Secondary or Tertiary Hyperparathyroidism 

GENERAL ENDOCRINOLOGY 

  • Artificial Intelligence in Endocrinology 
  • Health Disparities 
  • Healthcare Delivery and Health Services Research 
  • Healthcare Education in Endocrinology 
Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.